XPHYF News and Press, XPhyto Therapeutics Corp From 05/04/21

XPhyto Therapeutics Corp. recently announced it has entered into a distribution, storage and logistics agreement with a German distributor with an established network throughout Germany Germany holds promise due to regulations requiring mandatory weekly testing for its citizens; this ha...

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) , a bioscience technology accelerator, raised eyebrows when it announced that XPhyto Laboratories Inc., its Alberta subsidiary, added mescaline production to its psychedelic medicine development programs earlier this year ( https://i...

Power costs are among the highest costs for any facility that manufactures marijuana. The cannabis industry’s energy consumption has a negative effect on climate change as well as the environment. For environmentally conscious marijuana extraction companies that would prefer to oper...

Psychedelics have become a popular topic of discussion and research , with some states, including Oregon, going so far as to legalize psilocybin-assisted therapy, and the Multidisciplinary Association of Psychedelic Studies advancing MDMA-assisted therapy through the FDA as a treatment fo...

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) today announced that it has delivered 2,000 of its rapid 25-minute PCR tests ("Covid-ID Lab") to an established medical distributor in Israel for clinical evaluation of Covid-ID Lab for the purpose of commercial regulatory approval ...

XPhyto delivered 2,000 of its 25-minute PCR tests to Israeli distributor for clinical evaluation and regulatory approval Potential customers include government institutions, private healthcare providers and neighboring countries VANCOUVER, BC / ACCESSWIRE / April 28, 2021 / XPhy...

Former Republican Governor Rick Perry is backing legislation tabled by State Rep. Alex Dominguez, which pushes for psychedelic therapy treatments for veterans living with PTSD. The bill calls for a clinical study on psilocybin, which is the active ingredient found in magic mushrooms, to ...

As more and more states legalize cannabis in the United States, a debate on whether to regulate cannabis by its potency also appears to be gaining steam. Generally, many states that have legal cannabis markets base their tax on weight or sales price. However, the state of New York signe...

Researchers from the University of Copenhagen in Denmark suggest that psilocybin, which is the main active ingredient found in magic mushrooms, may give rise to speedy and lasting antidepressant effects because it increases neuroplasticity in the brain. The study, which was reported in the...

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) today announced its entry into an agreement with an established German pharmaceutical wholesaler and service provider for the distribution, storage and logistics of XPhyto's diagnostic products in Germany. According to the update, t...